SEC Form 4 · accession 0001140361-16-048045
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Jan 15, 2016 | M | 5,975 | $33.70 | A | 150,853 | D | |
| ResMed Common Stock | Jan 15, 2016 | S | 975 | $52.94 | D | 149,878 | D | |
| ResMed Common Stock | Jan 15, 2016 | S | 5,000 | $53.092 | D | 144,878 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | Jan 15, 2016 | M | 5,975 | D | Nov 11, 2010 | Nov 11, 2017 | ResMed Commmon Stock | 5,975 | 57,075 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vest 1/4 annually.